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Background: Gold nanoparticle toxicity research is currently leading towards the in vivo 
experiment. Most toxicology data show that the surface chemistry and physical dimensions of 
gold nanoparticles play an important role in toxicity. Here, we present the in vivo toxicity of 
5, 10, 30, and 60 nm PEG-coated gold nanoparticles in mice.
Methods: Animal survival, weight, hematology, morphology, organ index, and biochemistry 
were characterized at a concentration of 4000 µg/kg over 28 days.
Results: The PEG-coated gold particles did not cause an obvious decrease in body weight or 
appreciable toxicity even after their breakdown in vivo. Biodistribution results show that 5 nm 
and 10 nm particles accumulated in the liver and that 30 nm particles accumulated in the spleen, 
while the 60 nm particles did not accumulate to an appreciable extent in either organ. Transmis-
sion electron microscopic observations showed that the 5, 10, 30, and 60 nm particles located in 
the blood and bone marrow cells, and that the 5 and 60 nm particles   aggregated preferentially in 
the blood cells. The increase in spleen index and thymus index shows that the immune system 
can be affected by these small nanoparticles. The 10 nm gold particles induced an increase in 
white blood cells, while the 5 nm and 30 nm particles induced a decrease in white blood cells 
and red blood cells. The biochemistry results show that the 10 nm and 60 nm PEG-coated gold 
nanoparticles caused a significant increase in alanine transaminase and aspartate transaminase 
levels, indicating slight damage to the liver.
Conclusion: The toxicity of PEG-coated gold particles is complex, and it cannot be concluded 
that the smaller particles have greater toxicity. The toxicity of the 10 nm and 60 nm particles was 
obviously higher than that of the 5 nm and 30 nm particles. The metabolism of these particles 
and protection of the liver will be more important issues for medical applications of gold-based 
nanomaterials in future.
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Introduction
Gold-based nanomaterials have been focused on in diverse biomedical applications 
due to their unique surface chemistry and optical properties.1,2 Because of their 
strong and size-tunable surface plasmon resonance, fluorescence, and easy surface 
functionalization, gold-based nanomaterials have been widely used in biosensors, 
cancer cell imaging, photothermal therapy, and drug delivery.3–9 Recently, gold 
nanoparticles have been suggested as a novel radiosensitizer technique in radiotherapy, 
because their strong photoelectric absorption and secondary electron caused by gamma 
or X-ray irradiation can accelerate DNA strand breakage.10–12 Therefore, it was neces-
sary to investigate the toxicity of these materials.
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The toxicity of gold-based nanomaterials has been 
reported in recent years.13–18 In general, their toxicity depends 
on particle size and surface coating. The biosafety of metallic 
gold is well known. Gold was used in vivo in the 1950s, but 
functionalized gold particles showed obvious cytotoxicity.19 
Recently, the cytotoxicity of gold nanoparticles in human 
cells was studied in detail, and the results showed that 
these nanoparticles were nontoxic up to 250 mM, while 
ionic gold showed obvious cytotoxicity at 25 mM.20 Similar 
results were also reported recently using gold nanoparticles 
in radiotherapy experiments in vitro.21–28 However, in vitro 
systems cannot replicate the complexity of an in vivo 
system or provide meaningful data about the response of a 
physiological system to an agent. A case in point is carbon 
nanotubes.29 Manna et al29 found them to be toxic in vitro, 
whereas Schipper et al found no significant toxicity in vivo.30 
Similarly, Sayes et al found that in vivo toxicology results for 
fullerenes were very different from in vitro data.31
Therefore, the in vivo toxicity of gold nanoparticles is 
important. Very recently, size-dependent organ distribution 
of gold nanoparticles has been investigated, and the results 
showed that small gold nanoparticles of 5–15 nm had a wider 
organ distribution than that of larger gold nanoparticles of 
50–100 nm, with the liver and spleen being the dominant 
targeted organs.32–37 Meanwhile, it has been found that gold 
nanoparticles with a long blood circulation time can accumu-
late in the liver and spleen, and have obvious effects on gene 
expression.38–40 Furthermore, the toxicity and biodistribution 
of polyethylene glycol (PEG)-coated gold nanoparticles have 
also been investigated, and the results showed that 20 nm 
gold nanoparticles coated with TA-terminated PEG5000 were 
the most stable, and had the lowest toxicity among the 20, 
40, and 80 nm gold nanoparticles coated with TA-terminated 
PEG5000.36,38,41,42 However, the PEG-coated gold nanoparticles 
had a very low zeta potential which was significantly different 
from that of naked gold nanoparticles. For example, it has 
been reported that 13.5 nm PEG-coated gold nanoparticles 
can damage the liver and that 100 nm particles can be cleared 
partially.36,38 Therefore, it is desirable to clarify what size of 
PEG-coated gold particle is safe.
In previous work, we evaluated the in vitro and in vivo 
toxicity of naked gold nanoparticles.43,44 Here, we investigate 
the in vivo toxicity of 5, 10, 30, and 60 nm PEG-coated gold 
nanoparticles by evaluating biodistribution, blood chemistry, 
biochemistry, and characteristics on transmission electron 
microscopy. The outcome of this research will determine 
which size would be suitable for photothermal therapy 
and radiotherapy. Furthermore, the relevant hematology 
parameters of organs were analyzed.
Materials and methods
Fabrication of gold nanoparticles
The gold nanoparticles were fabricated following the 
classical method devised by Turkevich et al.45 A 100 mL 
aliquot of 0.01% chloroauric acid (HAuCl4⋅4H2O) solution 
was refluxed, and 0.8, 1.3, and 5 mL of 1% sodium citrate 
solution was then added to the boiling solution. Reduction 
of gold ions by the citrate ions was complete after 5 minutes, 
and the solution was then boiled for a further 30 minutes 
and left to cool to room temperature. This method yielded 
spherical particles with an average diameter of about 10, 30, 
and 60 nm. The small-sized gold nanoparticles of 5 nm were 
reduced by NaBH4. Subsequently, PEG-SH (Sigma-Aldrich, 
St Louis, MO) 1 mg was mixed with the gold nanoparticles 
and stirred for 1 hour to modify the surface of the gold 
nanoparticles covalently with PEG. The resulting PEG-coated 
gold nanoparticles were collected by centrifugation at 16,000 
rpm for 30 minutes and washed twice with distilled water. 
The PEG-coated gold nanoparticle solution was stored at 
4°C in order to prevent aggregation. Although the mean size 
varied slightly for each preparation, the size distribution was 
always found to be less than 20% of the standard deviation 
shown in Figure 1.
The zeta potential for the gold nanoparticles was 
determined using a Nano Zetasizer particle analyzer (Malvern 
Instruments, Worcestershire, UK). Data in the phase analysis 
were acquired in the light scattering mode at 25°C, and sample 
solutions were prepared by diluting the gold nanoparticles in 
10 mM phosphate-buffered saline solution (pH 7.0). The zeta 
potential of the 5, 10, 30, and 60 nm naked gold particles was 
−22.1, −28.23, −26.7, and −12.27 mV , respectively. Due to 
citric acid coating and the negative surface charge, PEG-SH 
coating decreased the zeta potential to −2.96, −1.55, −1.97, 
and −1.65 mV , respectively.
The size and morphology of the gold nanoparticles were 
analyzed by transmission electron microscopy using a Hitachi 
HF-2000 field emission high-resolution transmission electron 
microscope operating at 200 kV. The optical absorption 
spectra in a wavelength range of 200–850 nm was measured 
in a 5 mL glass cuvette using a DU800 spectrometer.
In vivo study design
The animals are purchased, maintained, and handled accord-
ing to protocols approved by the Institute of Radiation 
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Medicine, Chinese Academy of Medical Sciences. Male 
mice were obtained from the Institute of Radiation Medicine 
laboratory at 11 weeks of age and were housed on a 12-hour 
light/12-hour dark cycle, and had access to food and water 
ad libitum. In the size-dependent toxicology experiment, 
30 mice were randomly divided into five groups (six mice in 
each group) comprising one control group and four experi-
mental groups for administration of different sizes of gold 
nanoparticles. The mice received an intraperitoneal injection 
of approximately 200 µL of gold nanoparticle solution at a 
dose of 4000 µg/kg, based on the previously identified toxic 
dose in vivo.44 The mice were weighed following injection 
and assessed for behavioral changes every day for 28 days.
Hematology, biochemistry, and sample 
collection
Using a standard blood collection technique, blood was drawn 
from the saphenous vein into a potassium ethylenediamine 
tetra-acetic acid collection tube for hematology analysis. 
Analysis of standard hematological parameters was performed. 
For blood analysis, 300 µL of blood was collected from the 
mice. At 28 days, the mice were sacrificed by isoflurane anes-
thetic and exsanguinated with phosphate-buffered saline using 
an angiocatheter. One mouse from each treatment group was 
fixed with 10% buffered formalin following exsanguination. 
The liver, kidneys, spleen, heart, lungs, thyroid, lymph nodes, 
and bone marrow were then collected and weighed.
The spleen and thymus indices (Sx) can be expressed as:
  S
Weightof experimental organ 
Weightof experimental anima
x
mg
=
()
l
l () g
Transmission electron microscopic 
analysis
Bone marrow and blood cells were obtained after 28 days of 
administration of a nanoparticle dose of 4000 µg/kg. For the 
transmission electron microscopy analysis, the solution was 
centrifuged and the pellet fixed with 2.5% glutaraldehyde 
in 0.03 M potassium phosphate buffer (pH 7.4). The cells 
were postfixed with 1% osmium tetroxide in 0.1 M sodium 
cacodylate buffer, and 0.5% uranyl acetate in 0.05 M 
maleate buffer. Cells are then dehydrated in a graded series 
of ethanol and embedded in Epon resin. Ultrathin sections 
were cut and transferred onto 200 mesh uncoated copper 
grids, stained with uranyl acetate, counterstained with lead 
citrate, and observed using an Hitachi HF-2000 field emission 
high-resolution transmission electron microscope operating 
at 200 kV .
Results and discussion
Body weight and biodistribution
Figure 2 shows the variations in body weight of mice treated 
with different-sized gold nanoparticles. It can be seen that 
PEG-coated nanoparticles at a dose of 4000 µg/kg did not 
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Figure 1 Transmission electron micrographs and optical absorption of 5, 10, 30, and 60 nm PEG-coated gold particles.
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cause any deaths, and that body weight was slightly higher 
than in the control group during a 1-day observation period. 
The body weight of mice which received the 5 nm particles 
was slightly different from the other groups. During the 
study period, treatment with gold nanoparticles for 28 days 
did not cause obvious adverse effects on growth because 
no statistically significant differences in weight gain were 
observed between the gold nanoparticle-treated mice and 
the control mice. Furthermore, no abnormal clinical signs 
or behaviors were detected in either the controls and treated 
groups. Considered overall, treatment with gold nanoparticles 
did not induce any apparent toxicity in the mice. Necropsy 
at the end of the experiment did not show any macroscopic 
changes in the organs in any of the four treatment groups.
To demonstrate the biodistribution of the PEG-coated 
gold nanoparticles, gold concentrations in the heart, liver, 
spleen, and kidney after 28 days are shown in Figure 3. It 
can be seen that concentrations of the 5, 10, 30, and 60 nm 
particles in the heart were 214, 18, 8.6, and 37 µg/kg, 
respectively, with the 5 nm particles showing the highest 
concentration. These gold concentrations are markedly 
higher than previous biodistribution results.42 For the liver, 
the gold concentrations achieved by the 5, 10, 30, and 60 nm 
particles were 1797, 2898, 21, and 432 µg/kg, respectively. 
It was found that the 5 nm and 10 nm particles had a very 
high concentration in the liver, which is in good agreement 
with previous work.42 For the spleen, the gold concentrations 
achieved by the 5, 10, 30, and 60 nm particles were 628, 138, 
3363, and 721 µg/kg, respectively, with the 30 nm PEG-
coated gold particles showing the highest gold concentration. 
Finally, we showed that the gold concentrations achieved 
by 5, 10, 30, and 60 nm particles in the kidney were 390, 
48, 151, and 14 µg/kg, respectively, with the 5 nm particles 
showing the highest gold concentration. The 5 nm particles 
had the widest distribution, and the 60 nm particles showed 
the lowest concentration in all organs examined.
It is well known that the size and surface-capping of gold 
nanoparticles play an important role in their biodistribution in 
mice.36–41 It has been shown that naked gold can accumulate 
in the liver and spleen, and that the spleen and liver are the 
dominant target organs.32,33 Small-sized particles have a wider 
distribution, and larger-sized particles preferentially accu-
mulate in the liver and spleen.34,35 Furthermore, the   different 
surface charge on gold nanoparticles can influence their distri-
bution. PEG-coated gold nanoparticles have a neutral charge, 
so their dynamic behavior in mice should be different from 
that of naked and alternatively coated gold nanoparticles.36–38 
Therefore, we can conclude that the liver is the dominant target 
organ for 5 nm and 10 nm PEG-coated gold particles, and that 
the spleen is the dominant target organ for the 30 nm particles. 
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Figure 2 Body weight changes in mice for the 5, 10, 30, and 60 nm PEG-coated gold particles at a dose of 4000 µg/kg. The body weight of the treated mice was measured 
every 2 days. Each point represents the mean ± standard deviation of six mice. Data were analyzed using the Student’s t-test and the differences between the different doses 
and control group for each organ were not significant (P . 0.05).
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The 60 nm PEG-coated gold particles, similar to previously 
reported 100 nm gold particles, have a low distribution in all 
organs,36 and our results show that 60 nm gold particles can 
be metabolized partially by the liver and kidney. However, the 
smaller-sized 5 nm and 10 nm gold nanoparticles showed high 
accumulation and were difficult to metabolize. Indeed, previ-
ous biodistribution and pharmacokinetic studies of PEGylated 
gold nanoparticles have demonstrated high colloidal stability, 
nonaggregation, and nontoxicity for 20 nm PEG-coated gold 
nanoparticles.41 Other recent work carried out by Cho et al 
showed that 13 nm PEG-coated gold nanoparticles could 
induce acute inflammation and apoptosis in the liver, and were 
found to accumulate in the liver and spleen for up to 7 days 
after tail vein injection and to have a long blood circulation 
time.38 The results reported by Cho et al demonstrated organ 
micropathology, indicating that gold nanoparticles potentially 
induce long-term organ damage and toxicity.38
Morphology of gold nanoparticles  
in blood and bone marrow cells
Figure 4 shows transmission electron microscopic images of 
5, 10, 30, and 60 nm gold particles in blood and bone marrow 
cells after intraperitoneal injection at a dose of 4000 µg/kg 
for 28 days. The gold nanoparticles were found as mono-
dispersed particles within the bone marrow cells. The 5 nm 
particles were found in bone marrow cells, with no significant 
decrease in size, demonstrating that the small particles did 
not undergo any obvious breakdown. The 10, 30, and 60 nm 
particles could be found easily in both the intracellular and 
extracellular environment, which indicates that these gold 
particles have a long time retention in the bone marrow, 
and is in good agreement with previous work.36,38 However, 
in the blood cells, the morphology of the gold particles is 
different from that in bone marrow cells. The 5 nm nano-
particles showed good aggregation and hybridization with 
macromolecules, and could form 10–20 nm compounds. 
A similar phenomenon was observed for the 10 and 60 nm 
gold particles but not the 30 nm particles. The gold nano-
particles could be found in the blood cells easily, because 
of surface chemistry and endocytosis. It is noteworthy that 
the gold nanoparticles could still be found in the blood cells 
28 days after administration, which indicates that the gold 
nanoparticles have a long blood circulation time, and is 
again in good agreement with previous reports.38–40 It has 
been suggested that interaction between protein and the 
gold nanoparticles may be closely related to the toxicity of 
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Figure 3 Biodistribution of body weight in mice for 5, 10, 30, and 60 nm PEG-coated gold particles at the dose of 4000 µg/kg after 28 days of treatment. Spleen and liver 
were the main target accumulation organs. The 5 nm particles had a wide distribution in live, heart, kidney, while the 10 and 30 nm particles preferentially stayed in the liver 
and spleen, respectively.
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the latter.27 The surface of a PEG-coated gold nanoparticle 
probably has a low zeta potential, and cellular uptake of these 
nanoparticles is different from that of naked gold nanopar-
ticles. The PEG-coated gold nanoparticles can also interact 
with the cell by endocytosis and a conformational change in 
the protein, although PEG-coated gold particles have a low 
charge in the surface.
Endocytosis plays an important role in the interaction 
between gold nanoparticles and cells, and the PEG-
coated gold nanoparticles are different from naked gold 
nanoparticles. Recent quantitative evaluation revealed that 
the surface coating on gold nanoparticles could modulate 
endocytotic uptake pathways and cellular trafficking of the 
nanoparticles. The naked gold nanoparticles were shown 
to be taken up by macropinocytosis as well as by clathrin-
mediated and caveolin-mediated endocytosis.46–48 The 
difference is due to interactions with different proteins or 
lipids, related to mechanisms of uptake and endocytosis. 
Increased transcytosis of PEG-coated gold nanoparticles 
has been observed and a significant number of PEG-coated 
gold nanoparticles were measured.49 Thus, further study is 
necessary to understand how the mechanism of endocytosis 
and the protein adsorption process changes the protein 
conformation and the tendency of 5 nm and 60 nm PEG-
coated gold particles to aggregate.
Organ indices, hematology,  
and biochemistry results
Table 1 gives the organ weights of mice for the different nano-
particle sizes, and illustrates the effect of the PEG-coated gold 
nanoparticles on the organs. It can be seen that the weights of 
the heart, liver, spleen, lung, and kidneys showed no obvious 
variation at the dose of 4000 µg/kg. However, the weight of the 
thymus increased with increasing particle size, but no statisti-
cally significant differences were found in these data. To dem-
onstrate the immune reaction in the organs further, the organ 
indices for the thymus and spleen are shown in Figure 5. The 
average values of the thymus and spleen indices in the control 
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Figure 4 Transmission electron micrographs of 5, 10, 30, and 60 nm PEG-coated gold particles in bone marrow and blood cells 28 days after intraperitoneal injection at a 
dose of 4000 µg/kg. In the bone marrow cells, the gold particles can be found as monodispersed particles, and aggregations of 10 nm and 60 nm particles are found in the 
blood cells.
Table 1 Weights for the liver, lung, spleen, kidneys, heart, and thymus for 5, 10, 30, and 60 nm PEG-coated gold particles at a dose 
of 4000 µg/kg after 28 days
Dose (μg/kg) Control 5 nm 10 nm 30 nm 60 nm
Heart (g) 0.137 ± 0.019 0.149 ± 0.013 0.139 ± 0.017 0.173 ± 0.019 0.122 ± 0.008
Liver (g) 1.496 ± 0.203 1.248 ± 0.102 1.748 ± 0.326 2.520 ± 0.544 1.787 ± 0.222
Spleen (g) 0.125 ± 0.034 0.126 ± 0.010 0.143 ± 0.038 0.196 ± 0.073 0.229 ± 0.055
Lung (g) 0.183 ± 0.004 0.192 ± 0.018 0.199 ± 0.008 0.195 ± 0.028 0.176 ± 0.014
Kidneys (g) 0.301 ± 0.037 0.335 ± 0.033 0.373 ± 0.100 0.456 ± 0.019 0.330 ± 0.035
Thymus (g) 0.008 ± 0.011 0.099 ± 0.015 0.095 ± 0.010 0.104 ± 0.013 0.095 ± 0.025
Notes: Data were analyzed by the Student’s t-test and the differences between the different doses for each organ were not significant (P . 0.05 vs controls). All values 
represent the mean ± standard deviation of six mice.
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group were 2.3 and 3.3, respectively. The spleen indices of the 
mice treated with the 5, 10, 30, and 60 nm   particles changed to 
3.7, 4.1, 3.3, and 4.3, respectively, at a gold nanoparticle dose 
of 4000 µg/kg. The thymus indices for the mice treated with the 
5, 10, 30, and 60 nm particles changed to 2.2, 2.7, 3.3, and 2.5, 
respectively, at a gold nanoparticle dose of 4000 µg/kg. There 
were still no statistically significant differences between the 
treated groups and the control group, showing that injections of 
PEG-coated gold nanoparticles of different sizes do not cause 
obvious immune effects in either the thymus or spleen. The 
thymus index increased for all sizes, except for 10 nm. The 
spleen index increased for all particle sizes. Combining the 
  variations of body weight and biodistribution, it can be seen 
that the PEG-coated gold nanoparticles had only a slight influ-
ence on the mice compared with the naked gold nanoparticles. 
Moreover, the results imply that the spleen is one of the target 
organs for PEG-coated gold nanoparticles, which is in good 
agreement with previous work.32–42,50 The liver and spleen have 
been described as the two dominant organs for biodistribution 
and metabolism of gold nanoparticles.32–42
To quantify the toxicity of the PEG-coated gold 
  nanoparticles, the next important step is assessment of 
standard hematology and biochemistry, which is very useful 
for toxicity.50–53 We selected standard hematology markers 
for analysis, ie, platelets, hematocrit, hemoglobin, red blood 
cells, white blood cells, mean corpuscular volume, mean 
corpuscular hemoglobin, and mean corpuscular hemoglobin 
concentration. Nanoparticle size-dependent hematology 
results are presented in Figure 6. The white blood cells 
in mice treated with 5 nm and 30 nm particles decreased 
significantly, while white blood cells from mice treated with 
10 nm particles increased at a dose of 4000 µg/kg. Similarly, 
red blood cells from mice treated with 5 and 30 nm particles 
decreased significantly, while the red blood cells from 
mice treated with 10 nm and 60 nm particles increased. In 
addition, platelets, hematocrit, and hemoglobin from mice 
treated with 5 and 10 nm particles also increased, but this 
does not indicate a size-dependent trend associated with 
treatment. The mean corpuscular volume, platelets, mean 
corpuscular hemoglobin, and mean corpuscular hemoglobin 
concentration changed, but no statistically significant 
difference was found.
White blood cells are sensitive to physiological responses 
in mice. The rise in white blood cells seen in mice treated with 
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Figure 5 Size-dependent spleen and thymus indices of mice were calculated 28 days after 4000 µg/kg intraperitoneal injections.  
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10 and 60 nm particles indicate an inflammatory response, 
and the decrease in white blood cells seen in mice treated 
with 5 nm and 30 nm particles may be associated with infec-
tion. Red blood cells are derived from hemopoietic stem 
cells in the bone marrow. Following a series of maturation 
steps, and directed largely by the hormone erythropoietin, 
red blood cells enucleate and enter the circulatory system. 
Thus, any variation in red blood cell levels can be related 
to the hematopoietic system. The increase in red blood cells 
found in mice treated with 10 and 60 nm particles indicates 
that particles of this size have an effect on the hematopoietic 
system. The four sizes of gold nanoparticles used in this study 
could cause different reactions in the mice. The 10 and 60 nm 
particles caused a more serious toxic response than the 5 nm 
and 30 nm particles.
Finally, we investigated the biochemical effects of 
5, 10, 30, and 60 nm PEG-coated particles, as shown in 
Figure 7, including for alanine transaminase, aspartate 
transaminase, blood urea nitrogen, globulin, creatinine, total 
protein, albumin, and total bilirubin. It was found that alanine 
transaminase and aspartate transaminase in mice treated 
with the 10 and 60 nm particles increased significantly, 
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and globulin is decreased, indicating that the liver was 
damaged after injection of the nanoparticles. Creatinine 
levels in mice treated with the 60 nm particles decreased 
sharply, indicating kidney damage in the mice. Total protein 
and albumin in mice treated with the 10 and 60 nm particles 
also decreased after PEG-coated gold injection, while total 
bilirubin and blood urea nitrogen showed no significant 
change for any size of particles. These results show clearly 
that the 10 nm particles are highly toxic to the liver and that 
the 60 nm particles are toxic to both the kidney and liver. 
However, the 5 nm and 30 nm particles did not cause any 
significant liver and kidney damage.
Alanine transaminase and aspartate transaminase 
are mainly distributed in liver cells, and their levels rise 
with necrosis of liver cells. The levels of these enzymes 
correspond well with the extent of liver cell damage, and 
are commonly used indicators of liver function. These two 
enzymes are distributed differently among the liver cells. 
Alanine transaminase mainly exists in the cytoplasm of liver 
cells, whereas aspartate transaminase mainly exists in the 
cytoplasm and mitochondria of liver cells. Therefore, the 
increase in alanine transaminase in our mice treated with 10 
and 60 nm gold nanoparticles indicates damage to liver cells. 
However, their biodistribution shows that the concentration 
reached by 60 nm gold particles in the liver was not as high 
as that reached by 10 nm particles, indicate that the liver 
damage caused by the 60 nm particles was due to metabolism 
of the gold nanoparticles. In contrast, the 5 nm particles also 
reached high concentrations in the liver, but liver function 
was not significantly affected, showing that the 5 nm particles 
did not caused direct damage to the liver. The 5 nm particles 
are promising for the treatment of liver cancer without liver 
damage, which is very important for further work.
Creatinine is another important indicator of kidney 
function. Endogenous human creatinine is a product of 
muscle metabolism. In muscle, creatine mainly generates 
creatinine slowly through nonenzymatic dehydration, which 
is then released into the blood, with excretion in the urine. The 
serum creatinine concentration depends on the glomerular 
filtration rate. However, serum creatinine is not entirely 
consistent with the creatinine clearance rate, and creatinine 
clearance is more sensitive than serum creatinine. In early 
renal dysfunction (decompensated), creatinine clearance 
rate and serum creatinine are normal. When the glomerular 
filtration rate rises to above 50% of normal, serum creatinine 
begins to rise rapidly. Therefore, when the serum creatinine 
is significantly higher than normal, kidney function is 
seriously damaged. The decrease in creatinine seen in mice 
treated with the 60 nm particles is closely related to kidney 
function, although the kidney is not the main target organ 
for gold distribution. The 5 nm particles did not induce any 
kidney damage, but the 10 nm particles caused some damage 
by decreasing total protein and globulin.
In summary, the 60 nm particles induced serious toxicity 
and damage to the liver and kidney, but had a relatively low 
distribution in the liver, spleen, and kidney. It is proposed that 
this toxicity may be due to the metabolism of PEG-coated 
gold particles, which is similar to that previously reported 
for 100 nm PEG-coated gold particles.36 The toxicity of 
the 10 nm particles was also high, due to liver and kidney 
damage, as well as an inflammatory response, and large 
amounts of gold can accumulate in the liver. The present 
results are in good agreement with the results of Cho et al, 
showing that 13.5 nm PEG-coated gold particles can induce 
serious toxicity.36,38 Our 5 nm and 30 nm particles showed low 
toxicity, although accumulation of 5 nm particles did occur in 
the liver and kidneys, and the 30 nm particles preferentially 
remained in the spleen. Therefore, we suggest that 10 nm 
PEG-coated gold particles are not sufficiently safe to be 
administered at a concentration of 4000 µg/kg. If we want to 
use these particles to encapsulate drugs for use in the clinical 
setting, metabolism must be considered. High accumulation 
of gold may induce long-term toxicity. The most important 
finding for the size-dependent toxicity of PEG-coated gold 
nanoparticles are that the 5 nm and 30 nm particles are safe, 
but the 10 nm and 60 nm particles are toxic, which is not 
consistent with previous in vitro findings, ie, the smaller the 
particle, the greater the toxicity.
Conclusion
A size-dependent in vivo toxicity study of PEG-coated 
gold nanoparticles in mice was carried out. In the study 
animals, survival, weight, hematology, biochemistry, and 
morphology were characterized 28 days after administration 
of the gold nanoparticles at a concentration of 4000 µg/kg. 
Biodistribution studies showed that the spleen and liver are 
two dominant target organs. Our results showed that the 
5 nm and 10 nm particles mainly accumulate in the liver, 
and that the 30 nm particles preferentially accumulate in 
the spleen. The 60 nm particles had a wider distribution, 
with limited accumulation in the organs. Blood chemistry 
revealed that white blood cells were increased in mice treated 
with the 10 nm and 60 nm particles, while those treated 
with the 5 nm and 30 nm particles showed decreased white 
blood cells. Furthermore, alanine transaminase and aspartate 
transaminase increased in mice treated with the 10 and 60 nm 
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particles, while creatinine decreased with the 60 nm particles, 
indicating that the 10 and 60 nm particles caused liver and 
kidney damage. The present work clearly shows that 10 and 
60 nm PEG-coated gold nanoparticles are not sufficiently 
safe, and that the 5 and 30 nm particles have relatively low 
toxicity. These conclusions are very important for future 
cancer therapy, drug delivery, and diagnosis.
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